Literature DB >> 1656920

Virus reactivation in pigs latently infected with a thymidine kinase negative vaccine strain of pseudorabies virus.

W L Mengeling1.   

Abstract

Attenuated, gene-deletion mutants of pseudorabies virus (PRV) were tested for their ability to establish a reactivatable latent infection in pigs. The viruses (designated A, B, and C) were from each of three vaccines commercially available in the United States. Viruses A and C were similar in that they had genetically engineered gene deletions for thymidine kinase (TK) and glycoprotein X (gX); however, they had been prepared from genetically different parental strains. Virus B was TK positive, but had a naturally occurring gene deletion for glycoprotein I (gI). Four pigs were exposed oronasally to each of the viruses, and 10 weeks later they were treated with dexamethasone in an attempt to induce virus reactivation. All of the viruses replicated after initial exposure as evidenced by virus isolation from nasal swabs and the pigs' immune responses. Virus reactivation was subsequently induced by dexamethasone treatment in two of four pigs exposed to virus A. Notably, both pigs remained free of serum antibody for gX. Restriction endonuclease analysis and tests for TK activity and the presence of gX indicated that reactivated virus was similar, if not identical, to virus A used to establish latent infection. Virus shedding after dexamethasone treatment was not identified for either of the other pigs exposed to virus A nor for any of the pigs exposed to viruses B or C. The results indicated that attenuated, TK-negative PRV can establish a reactivatable, latent infection in pigs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656920     DOI: 10.1007/bf01310949

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

1.  A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes.

Authors:  C C Marchioli; R J Yancey; R C Wardley; D R Thomsen; L E Post
Journal:  Am J Vet Res       Date:  1987-11       Impact factor: 1.156

2.  Map location of the thymidine kinase gene of bovine herpesvirus 1.

Authors:  L J Bello; J C Whitbeck; W C Lawrence
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Latent pseudorabies virus infection in swine detected by RNA-DNA hybridization.

Authors:  D E Gutekunst
Journal:  Am J Vet Res       Date:  1979-11       Impact factor: 1.156

4.  Exposure of pigs to a pseudorabies virus formed by in vivo recombination of two vaccine strains in sheep.

Authors:  J B Katz; L M Henderson; G A Erickson; F A Osorio
Journal:  J Vet Diagn Invest       Date:  1990-04       Impact factor: 1.279

5.  Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1.

Authors:  R B Tenser; K A Hay; W A Edris
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

6.  Programs for the elimination of pseudorabies virus from large herds of swine.

Authors:  D G Thawley; R B Morrison
Journal:  J Am Vet Med Assoc       Date:  1988-07-15       Impact factor: 1.936

7.  Thymidine plaque autoradiography of thymidine kinase-positive and thymidine kinase-negative herpesviruses.

Authors:  R B Tenser; J C Jones; S J Ressel; F A Fralish
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

8.  Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.

Authors:  S Kit; M Kit; E C Pirtle
Journal:  Am J Vet Res       Date:  1985-06       Impact factor: 1.156

9.  Vaccines against Aujeszky's disease: evaluation of their efficacy under standardized laboratory conditions.

Authors:  P W de Leeuw; J T van Oirschot
Journal:  Vet Q       Date:  1985-07       Impact factor: 3.320

10.  Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus.

Authors:  S McGregor; B C Easterday; A S Kaplan; T Ben-Porat
Journal:  Am J Vet Res       Date:  1985-07       Impact factor: 1.156

View more
  7 in total

1.  Characterization of field isolates of suid herpesvirus 1 (Aujeszky's disease virus) as derivatives of attenuated vaccine strains.

Authors:  L S Christensen; I Medveczky; B S Strandbygaard; Z Pejsak
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Comparison of the protective response induced by NYVAC vaccinia recombinants expressing either gp50 or gII and gp50 of pseudorabies virus.

Authors:  S L Brockmeier; W L Mengeling
Journal:  Can J Vet Res       Date:  1996-10       Impact factor: 1.310

Review 3.  Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.

Authors:  L Jacobs
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs.

Authors:  W L Mengeling; S L Brockmeier; K M Lager
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  Latency of a thymidine kinase-negative pseudorabies vaccine virus detected by the polymerase chain reaction.

Authors:  D M Volz; K M Lager; W L Mengeling
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant.

Authors:  C A Whetstone; J M Miller; B S Seal; L J Bello; W C Lawrence
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 7.  The Role of Latency-Associated Transcripts in the Latent Infection of Pseudorabies Virus.

Authors:  Jiahuan Deng; Zhuoyun Wu; Jiaqi Liu; Qiuyun Ji; Chunmei Ju
Journal:  Viruses       Date:  2022-06-24       Impact factor: 5.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.